Central Serous Chorioretinopathy (CSC) Unknown Status Phase 2 Trials for Aflibercept (DB08885)

Also known as: Central Serous Chorioretinopathy / Central Serous Retinopathy (CSR) / Central Serous Retinopathy / Serous macular detachment

IndicationStatusPhase
DBCOND0050251 (Central Serous Chorioretinopathy (CSC))Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01710332The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous ChorioretinopathyTreatment